Rapid Global Growth
Classys Global Device Sales Near 50,000 Milestone Amid Strategic Portfolio Expansion
Classys Inc., a South Korean medical aesthetics company, expects to sell more than 50,000 devices worldwide this year — a milestone that marks its rapid expansion beyond its core HIFU and MRF platforms Yahoo Finance. The company is now rolling out new categories including microneedle radiofrequency (MNRF), laser systems, and dermabrasion devices to fuel growth across global markets.
Exports excluding Brazil surged 29% year over year, signaling strong demand internationally ADVFN. By mid-2024, Classys had installed over 22,000 HIFU devices and 4,000 MRF devices globally, building a foundation to launch new products like Quadessy worldwide and introduce Viclara in Europe.
HIFU and MRF: The Core That Built Scale
HIFU (high-intensity focused ultrasound) and MRF (microneedling radiofrequency) have been Classys's anchor products for years PRNewswire. Together, these lines now account for over 26,000 installed units globally. This massive base gives Classys a trusted customer network and recurring revenue from upgrades and new treatments.
Expanding Into Laser and Dermabrasion Markets
Classys is not resting on its legacy platforms. The company has added MNRF, laser systems, and dermabrasion devices to diversify its product mix Barchart. This move lets the company serve more customer needs — from non-invasive skin tightening to resurfacing treatments. It also reduces dependence on any single device category.
Global Export Growth Outpaces Total Sales
Exports outside Brazil jumped 29% year over year, outpacing overall sales growth UK Yahoo Finance. This metric shows Classys is gaining market share in competitive regions like North America, Europe, and Asia. The company's ability to grow exports faster than domestic sales signals strong international demand.
New Product Launches Set Up Next-Wave Growth
Classys plans to roll out Quadessy globally and launch Viclara in Europe, leveraging its 22,000+ unit installed base to drive adoption Yahoo Finance. These next-generation platforms represent the company's bet on sustained double-digit growth. With 50,000 devices expected to ship this year, Classys is positioned as a serious contender in the $15+ billion medical aesthetics market.
Sentiment
NeutralPublishers
5
Articles
5
Reach
5
